It was discovered that patients who had been previously diagnosed with COVID-19 were more likely to experience symptoms that were indicative of GCA, such as headache, vision changes, increased CRP level, and findings from a temporal artery biopsy or high-resolution MRI. Here, CRP is linked to temporal arteritis.